PA
CAAP icon

PharVision Advisers’s Corporacion America CAAP Stock Holding History

PharVision Advisers’s Portfolio CAAP Stock Details CAAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,455
Closed -$532K – 177
2025
Q4 		$532K Sell
20,455
-15,731
-43% -$352K 0.27% 29
2025
Q3 		$656K Buy
+36,186
New +$729K 0.37% 6

Other funds holding CAAP

HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

PharVision Advisers's CAAP Position: Q1 2026 in Review

PharVision Advisers sold out of Corporacion America (CAAP) in Q1 2026, closing a stake of 20,455 shares — an estimated $532K sold.

PharVision Advisers first reported a position in CAAP in Q3 2025 and held it in 2 quarters. The position peaked at $656K in Q3 2025. 102 funds tracked by Wall St. Rank hold CAAP as of Q1 2026.

  • PharVision Advisers reported no remaining Corporacion America position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 20,455 Corporacion America shares in Q1 2026, an estimated $532K.
  • PharVision Advisers first reported a position in Corporacion America in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Corporacion America position peaked at $656K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held Corporacion America as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.